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Background: The Mushua Innu of Natuashish, Labrador, Canada seem to have a high rate of childhood eczema.
Anecdotally this problem seems to be more common now than 20 years ago. There has been speculation that this
could be related to food sensitization that may have arisen coincident with a move away from a traditional Innu
diet. We undertook to assess the prevalence and severity of pediatric eczema in Natuashish (population 792), and
investigate the level of sensitization to common food antigens.
Methods: Over a three-month period we performed a population survey of all children in the community from the
ages of 2–12 inclusive. The one-year prevalence of eczema was assessed using the United Kingdom Working Party’s
diagnostic criteria, and graded on the Nottingham Severity Scale. All children with eczema and twice as many
age/sex matched controls were offered complete blood counts, total IgE, and food specific IgE levels for egg
white, cow’s milk protein and wheat.
Results: One hundred and eighty two (95% of the eligible children) were assessed. Of the 182 children examined
eczema was diagnosed in 30 (16.5%) - 22 females and 8 males. The majority of children with eczema (20/30) were
classified as being in the moderate and severe category. Of the 22 with eczema and 40 controls who consented
to venipuncture all but 3 had IgE levels above the lab's reference range. Food specific antibody assays showed
that 32, 23, and 5 percent of children with eczema were sensitized to egg, milk, and wheat respectively. None of
the controls were sensitized.
Conclusions: The children of Natuashish, Labrador have a high rate of eczema, much of it graded as moderate or
severe. IgE levels were markedly elevated in children with and without eczema, with average values at least ten-fold
higher than other populations. There is no evidence of an unusual amount of sensitization to egg, milk or wheat.Background
Eczema is a chronic relapsing disease that is character-
ized by erythematous pruritic skin lesions. Many factors
affect its prevalence and severity. Susceptibility genes
express a defective barrier protein (filaggrin), which
increases epidermal permeability and water loss [1,2].
The immune response to this permeability is affected by
infectious and environmental factors [2,3]. Its economic
burden is considerable, and caregiver stress can exceed
that of caring for a child with diabetes [4]. Population
surveys using the ISAAC protocol [5] show rates thatCorrespondence: robert.forsey@lghealth.ca
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countries, 8.5% in Canada, and 15.9% in Japan. The pic-
ture is fluid; some high prevalence countries have shown
a decrease, while many developing countries with a low
prevalence have experienced increases [6,7]. Prevalence
in the former East Germany rose to equal that of West
Germany after reunification [8]- too quickly to be ex-
plained by gene frequency changes, but coinciding with
a more “Western” diet and other social changes.
Much time has been spent examining potential
influences- the literature is complex and at times
contradictory. Dietary and environmental changes parallel
the rising rate of eczema although causality remains un-
proven [9]. Gender, nutrition, number of siblings, allergic
status, exposure to acetaminophen or antibiotics, vitaminhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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ure to dust, animal dander, molds, tobacco smoke, heating
systems and aeroallergens may also play a role [14,15].
Evidence is contradictory about the role of breastfeeding
[16,17]. Western and urban populations tend to have
more eczema than those that are oriental and rural [5].
Less exposure to childhood infections may cause higher
rates of atopic disease (the Hygiene Hypothesis) [18].
The connection between atopy and eczema has been
debated- the link is stronger in severe (hospitalized) pa-
tients and weaker in the community setting [19], stron-
ger in affluent countries and weaker in developing ones
[20]. One early study noted elevated IgE levels in 43% of
patients with eczema [21], and another in 2004 noted
higher IgE levels in severe cases [22]. Eczematous chil-
dren commonly have food sensitization- 40% with mod-
erate/severe eczema have food allergies [23]. Milk and
eggs can provoke flares in infants and some adolescents
[24]. The 2007 GA2LEN/EAACI recommendation [25]
to consider food triggers is noteworthy, and there are
plausible mechanisms to implicate IgE in chronic in-
flammation [26]- in addition to its well-known role in
acute hypersensitivity.
Little Canadian research has been done, although a
1999 questionnaire compared prevalence rates in the
Canadian cities of Saskatoon, Saskatchewan (17.3%) and
Hamilton, Ontario (15.4%) [27]. It is worth noting that
the children in this study were not examined, and that
reported rates in surveys can be much higher (even
double) rates observed in studies that include a clinical
assessment [28].
There is limited information on eczema in circumpolar
and First Nations communities. Sami children had a
higher rate than their Norwegian schoolmates [29], and
affluent Norwegian children had more than Russians
[30]. Inuit schoolchildren in northern Quebec had low
rates of exercise induced asthma and atopy, although
eczema rates were not assessed in this study [31].
This project was designed to assess the prevalence
of childhood eczema in Natuashish, and the level of
sensitization to foods now common in the diet of the
Innu.
Methods
Data source and population
The Mushua Innu of Labrador led a nomadic exist-
ence until 1967 when they were settled into the com-
munity of Davis Inlet. The entire community relocated
to the newly constructed town of Natuashish in 2004
in hopes of improving housing and basic community
services. Health care to the 725 inhabitants of Nat-
uashish is provided by a station staffed by three
nurses, with regular visits from a physician based in
Goose Bay.Community members and clinicians noted a lot of ec-
zema, apparently more than in other coastal communities.
Nurses reported seeing fewer skin infections but more
eczema over the past decades. The emergence of this
problem over two decades does parallel the adoption of
a less traditional, more “Westernized” diet. Traditional
foods for the Innu would include caribou meat, fish
and berries, with little milk, egg and less flour.
The Mushua Innu Health Commission and the
band council requested further investigation. Memor-
ial University of Newfoundland’s Human Investigations
Committee, the Labrador-Grenfell Health Research
Review Committee, and the Mushua Innu Band Council
approved the project. It was conducted in accordance with
the Canadian Institutes of Health Research: Guidelines
for Health Research involving Aboriginal People and
the Tri-Council Policy Statement: Ethical Conduct for
Research Involving Humans. Consent discussions, ques-
tionnaires and interviews were offered in either Innuamun
or English, and written informed consent was obtained
from the children’s parents/guardians.
Assessment of prevalence and severity of eczema
The study was publicized through the clinic and local
radio station. Community birth and public health records
were used, and all children were identified. Over a three-
month period (June-August 2008) those between the ages
of 2 and 12 years were assessed. The one-year prevalence
of eczema was established using the United Kingdom
Working Party’s (UKWP) diagnostic criteria [32] (see
section ‘‘United Kingdom Working Party’s diagnostic
criteria’’). We assessed the one-year (rather than the
point) prevalence because eczema is typically an evanes-
cent condition-examination alone will miss some who are
currently in remission. This approach improves sensitivity
[33,34]. Eczema was graded using the Nottingham
Severity Score [35].
Assessment of eosinophil, total and food specific
IgE levels
All thirty children with eczema were offered a complete
blood count (CBC), total and food specific IgE (FSIgE)
levels for egg white, cow’s milk protein, and wheat.
Twenty-two consented, and 40 age and sex matched
controls were likewise tested.
Blood samples were collected in Natuashish. CBC’s
were run at the Labrador Health Center in Goose Bay.
Serum was frozen and transported to the immunology
laboratory at the Health Sciences Center, St. John’s for
total IgE and FSIgE levels (IMMULITE® 2500 -Siemens).
As per standard we accepted FSIgE levels of ≥0.35
kIU/L to indicate sensitization. This cutoff is far below
that required to make a diagnosis of food allergy (6 kIU/
L-eggs, 32 kIU/L-milk, and > 100 kIU/L-wheat) [36,37].
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To meet the UKWP diagnostic criteria, the child must
have: a history of an itchy skin condition in the last 12
months plus three or more of the following:
 a history of a rash in the skin creases (folds of elbows,
behind the knees, front of ankles or around the neck);
 a personal history of asthma or hay fever (or history
of atopic disease in a first degree relative for
children under 4 years of age);
 a history of generally dry skin in the last year;
 onset under the age of two years;
 visible flexural dermatitis (or dermatitis of cheeks
and the outer aspects of limbs in children <4 years)
as determined on clinical exam.
Statistical analysis/comparison with other populations
We used SPSS Statistics v17.0. Rates from four other
prevalence studies were compared with our rate using
two tailed paired Fisher’s Exact Test. Laboratory results
were compared using Student’s t-test.
Results
Virtually all children who were living in Natuashish that
summer were assessed. Census data suggests there were
approximately 192 children in that age range, and we
saw 182. Examination findings are summarized in Table 1.
Thirty children met the UKWP diagnostic criteria for ec-
zema. The one-year prevalence rate was 16.5%. The pro-
portion of females with eczema (22 out of 102) was
significantly higher than the proportion of males (8 out of
80). Forty-three percent (13 children) of the eczema cases
were severe, 23% (7) were moderate, and the remaining
cases were mild. Table 2 summarizes the laboratory
results-all but 3 children (in both eczema and control
groups) had elevated total IgE levels. Food specific anti-
body assays showed that 32, 23, and 5 percent of children
with eczema were sensitized to egg, milk, and wheat
respectively. None of the controls were sensitized.Table 1 Clinical assessment of 182 children in Natuashish
Age in years
Mean (SD) 6.35 (2.9)
Female sex
# females (%) 102 (56)
Eczema present (UKWP criteria)
# (%) 30 (16.5)
Females with eczema*
# eczema/total # of females (%) 22/102 (21.6)
Males with eczema*
# eczema/total # of males (%) 8/80 (10)
*females were significantly more likely to have eczema than males (p = 0.037).Discussion
Our 16.5% prevalence is higher than reported in Australia
[38], Italy [39], London [34] and Scotland [40] and similar
to high prevalence areas like Japan [41] (Table 3). Our fe-
male/male ratio of 2:1 was higher than the 1.2:1 ratio re-
ported elsewhere [28,42]. Sex related differences in eczema
subtypes have been reported-eczema in boys has been more
often associated with sensitization to various allergens (ex-
trinsic) whereas girls were more likely to be intrinsic [43].
A high number (67%) of the children with eczema were in
the moderate or severe category. The Danish DARC study
[44] of children with eczema showed 43% were in the
moderate-severe categories, and a Japanese study [45] graded
13-19% of their cases as moderate-severe. Two Australian
studies reported rates of 36 and 13 percent [38,46].
An unexpected finding was elevated levels of IgE in all
but three of the 62 subjects (those with eczema and those
in the eczema-free control group). This finding was verified
with repeat samples. The lab performed no dilutions be-
yond 2000 kIU/L so it is impossible to calculate mean IgE
levels for both groups. That being said-the lowest these
means could possibly have been were 1247 kIU/L in the
eczema group and 685 kIU/L in the controls. These two
figures were arrived at by assuming a best-case scenario in
which the 15 samples reported as “>2000 kIU/L” were 2001
kIU/L (one unit above the cut-off). These two numbers
contrast markedly with typical population means and me-
dians that are in the range of 18–122 kIU/L [47-50]. Even
atopic children are usually in the 250–380 range [47,49].
There is no obvious cause for this-parasitic infections are
not common in Natuashish, and normal eosinophil counts
suggest this explanation is unlikely. One study of Inuit chil-
dren in Alaska found that 17% had IgE levels > 1000 kIU/L,
although their mean was still only 122 kIU/L [51]. There is
also a report of unexplained hyperimmunoglobulinemia E
(mean 11,850 kIU/L) in the Haurorania Indians of Ecuador
[52]. Neither the Alaskan children nor the Ecuadorians
showed high rates of conditions that are associated with
elevated IgE levels such as atopic disease, dermatitis, B
cell neoplasia, hypersensitivity reactions and parasites.
In our study children with eczema showed sensitization
rates comparable to those reported elsewhere. On average
50% of children and 35% of adults with eczema are sensi-
tized to common allergens [53]. Sensitization is in fact
common in the general population-unselected children in
Denmark [44,54], Greenland [49], Russia and Finland [55]
showed rates ranging from 0-14%.
Limitations
There would be children who were missed in this study.
Community members do travel back and forth to visit
other communities in Labrador and northern Quebec.
Eczema severity scoring may have been affected by the fact
that the children’s caregivers (not the examiner) indicated
Table 2 Laboratory comparison of eczema and control groups
Eczema
(N = 22)
Eczema-free controls
(N = 40)
p value
(where applicable)
Age in years: Mean (SD) 5.48 (2.50) 5.37 (2.29)
Female sex: # (%) 14 (64) 31(77.5)
Eosinophil count: (SD) (×109/L)
0.73 (0.08) 0.96 (0.14) 0.245
IgE levels*: (kIU/L) # (%)
0-52 0 (0) 2 (5)
53-199 3 (13.6) § 10 (25) §
200-1999 10 (45.5) 22 (55.0)
≥2000 9 (40.9) 6 (15.0)
Food specific IgE: (kIU/L) Mean (SD)
Egg 2.7 (6.4) 0.2 (0.5) 0.010
Milk 0.29 (0.61) 0.00 (0.02) 0.005
Wheat 0.57 (2.53) 0.00 (0.02) 0.160
# of children with food-specific antibody levels ≥ 0.35 kIU/L: # (%) Egg 7 (32) 0 (0)
Milk 5 (23) 0 (0)
Wheat 1 (5) 0 (0)
*Normal IgE: Age 2–9 years = 0–52 kIU/L, Age >9 years = 0–199 kIU/L.
§All but one of these 13 children were in the 2–9 year age group, thus 12/13 had IgE levels above the age appropriate reference range.
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less, the 30 children with eczema had it for an average of
six months per year and averaged three nights per week of
interrupted sleep so many of these cases were not mild. We
also limited the number of antigens tested-others that mayTable 3 Eczema rates (UKWP diagnostic criteria)-a
comparison between Natuashish and other pediatric
populations
Location One year eczema prevalence p value
Natuashish 16.5
Age 2-12
Australia (1999) [38]
N = 2491 10.8 0.027*
Age 4-18
Italy (2003) [39]
N = 1369 6.9 0.0001*
Age 9
London (1996) [34]
N = 877 8.5 0.002*
Age 3-11
Japan (2007) [41]
N = 3849 15.4 0.600
Elementary school students
(first and sixth graders)
Lothian, Scotland (1996) [40]
Number unspecified 8.1 N/A
Age 2-11
*The Australian, Italian and London studies all had significantly lower rates
than Natuashish.contribute to eczema were not formally studied (although
subsequent testing did show that approximately 25%
of the children with eczema were sensitized to house
dust mite and cat dander). We were unable to ex-
plore the possibility of non-IgE mediated food trig-
gers, although food antigen specific T cells and other
inflammatory mediators can play a role [1,56].
The fact that food sensitization coexists with eczema
does not necessarily prove a cause and effect relationship-
monosymptomatic, late phase eczematous reactions after
food ingestions are not common [44], and food sen-
sitization cannot always be linked to a worsening of the
eczema [54]. Inappropriate use of elimination diets may
cause other health problems. A recent Cochrane meta-
analysis of the use of exclusion diets to improve estab-
lished eczema [57] found little evidence to support the
practice, although it is notable that subjects in eight out
of the nine studies in this analysis were not assessed for
possible food sensitization-the one study of infants with
known egg sensitization [58] did show an improvement
when an elimination diet was instituted.
Conclusions
The issue of eczema in Natuashish is a substantial pub-
lic health concern, with a high one-year prevalence and
many moderate-severe cases. Many more females than
males were affected. Unexpectedly, IgE levels exceeded
the normal range in 59 of the 62 eczematous and non-
eczematous children, many by a factor of tenfold. Sen-
sitization rates in the group of children with eczema
were comparable to what has been observed in other
studies.
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